Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel
- 1 January 2000
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 17 (2) , 175-182
- https://doi.org/10.1023/a:1007565230130
Abstract
Purpose. Paclitaxel is currently administered i.v. as a slow infusion of asolution of the drug in an ethanol:surfactant:saline admixture. However,poor solubilization and toxicity are associated with...Keywords
This publication has 21 references indexed in Scilit:
- Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.1998
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProceedings of the National Academy of Sciences, 1997
- A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol)Journal of Pharmacy and Pharmacology, 1997
- Pharmaceutical and Physical Properties of Paclitaxel (Taxol †) Complexes with Cyclodextrins ‡Journal of Pharmaceutical Sciences, 1995
- Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing LiposomesPharmaceutical Research, 1994
- Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model.1993
- Sterile Filtration of a Parenteral EmulsionPharmaceutical Research, 1992
- Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.1991
- A New Parenteral Emulsion for the Administration of TaxolPharmaceutical Research, 1987
- Suspected anaphylactic reaction to Cremophor EL.BMJ, 1980